|
UPDRS motor part IIIa
| |
---|
Id
|
Sex
|
Age (yrs)
|
BMI
|
Duration of PD (yrs)
|
Tremor
|
Rigidity
|
Bradykinesia
|
Total
|
H&Y
|
Previous fallsb
|
No of falls
|
FOGc
|
Fear of fallingd
|
Gait speed (m/s)e
|
Physical activity (steps per day)f
|
---|
1
|
F
|
66
|
17.4
|
5
|
4
|
7
|
20
|
41
|
2
|
Y
|
1
|
N
|
N
|
1.27
|
3656
|
2
|
M
|
72
|
23.5
|
1
|
2
|
13
|
21
|
32
|
2
|
N
|
–
|
N
|
N
|
0.80
|
2157
|
3
|
M
|
80
|
22.8
|
5
|
2
|
18
|
16
|
33
|
3
|
Y
|
12
|
N
|
Y
|
1.29
|
1343
|
4
|
M
|
65
|
27.1
|
1
|
3
|
6
|
21
|
50
|
2
|
N
|
–
|
N
|
N
|
1.53
|
8728
|
5
|
F
|
72
|
22.9
|
2
|
3
|
5
|
16
|
45
|
3
|
Y
|
1
|
N
|
Y
|
1.22
|
6593
|
6
|
F
|
83
|
23.5
|
2
|
9
|
7
|
14
|
48
|
3
|
N
|
–
|
N
|
Y
|
0.97
|
781
|
7
|
M
|
74
|
26.0
|
2
|
10
|
6
|
20
|
38
|
2
|
Y
|
6
|
N
|
N
|
1.16
|
1553
|
8
|
M
|
69
|
25.4
|
5
|
7
|
8
|
11
|
31
|
2
|
Y
|
3
|
Y
|
N
|
1.13
|
3258
|
9
|
M
|
63
|
21.9
|
6
|
8
|
15
|
20
|
47
|
2
|
Y
|
2
|
N
|
N
|
1.40
|
7558
|
10
|
M
|
70
|
26.0
|
7
|
8
|
12
|
19
|
39
|
2
|
N
|
–
|
N
|
Y
|
1.13
|
10696
|
Mean
|
–
|
71
|
23.8
|
3
|
6
|
10
|
18
|
40
|
–
|
–
|
–
|
–
|
–
|
1.19
|
4632
|
-
Abbreviations: BMI Body Mass Index; PD Parkinson’s disease; UPDRS Unified Parkinson’s Disease Rating Scale; H&Y Hoehn and Yahr, FOG freezing of gait
-
aMaximum total score is 108 points (higher score = higher severity of motor symptoms). Sub-scores were calculated as follows: tremor; sum of item 20–21, rigidity; sum of item 22, and bradykinesia; sum of item 23–26 and item 31
-
bFalls assessed retrospectively the previous 12 months and defined as an unexpected event in which the participants came to rest on the ground, floor, or lower level
-
cFreezing of gait assessed by item 14 of UPDRS activities of daily living part II (a score ≥2 indicated freezing of gait)
-
dFear of falling assessed with a single-item question (“In general, are you afraid of falling?”)
-
eSelf-selected gait speed assessed with an electronic walkway system (GAITRite® system, CIR Systems, Inc., Haverton, PA, USA)
-
fPhysical activity level assessed by accelerometry (Actigraph GT3X+) in free-living conditions during 4 – 7 consecutive days